Acute respiratory failure as a rare presentation of non-fibrotic hypersensitivity pneumonitis: Case series

RATIONALE: Hypersensitivity pneumonitis (HP) is an increasingly recognized interstitial lung disease caused by exposure to inhaled, mostly organic, antigens. The non-fibrotic type of HP generally follows a benign course. We present 3 patients with a rare presentation of non-fibrotic HP-acute respiratory failure. PATIENT CONCERNS: 2 females and 1 male, presented to the pulmonary department due to resting dyspnea, cough and low-grade fever. Arterial blood gases revealed profound hypoxemia. No relevant abnormalities were found in the blood tests. In high-resolution computed tomography (HRCT), signs of extensive interstitial lung disease were present. Infection was excluded based on genetic testing and cultures. Pulmonary function tests revealed decrease in forced vital capacity (FVC) and transfer factor of the lungs for carbon monoxide (TLco). DIAGNOSES: Non-fibrotic HP was diagnosed based on positive exposure to organic antigens, characteristic lung HRCT pattern, and bronchoalveolar lavage lymphocytosis (in 2 cases). INTERVENTIONS: Oxygen therapy was implemented through the nasal tube, accompanied by intravenous and subsequently oral steroids, gradually tapered. OUTCOMES: Rapid clinical improvement, near-complete regression of interstitial lung disease, significant increase in lung volumes and lung transfer factor for carbon monoxide were observed and maintained with low-dose therapy. LESSONS: Non-fibrotic HP rarely presents as a life-threatening interstitial lung disease, requiring immediate immunosuppressive treatment. In some patients with extensive lung involvement, prolonged steroid therapy is necessary to achieve complete resolution of lung opacities and clinical improvement.

Authors

Publication Details

Journal
Medicine
Published
2026-05-29
DOI
https://doi.org/10.1097/md.0000000000049011
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Acute respiratory failure as a rare presentation of non-fibrotic hypersensitivity pneumonitis: Case series

Adriana Roży, Lilia Jakubowska, Piotr Radwan-Röhrenschef, Monika Szturmowicz et al.
Medicine
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Acute respiratory failure as a rare presentation of non-fibrotic hypersensitivity pneumonitis: Case series

Adriana Roży, Lilia Jakubowska, Piotr Radwan-Röhrenschef, Monika Szturmowicz, Iwona Bartoszuk, Lucyna Opoka, Małgorzata Sobiecka, Małgorzata Jędrych, Kamila Deutsch, Witold Z. Tomkowski, Katarzyna B. Lewandowska
article en

Abstract

RATIONALE: Hypersensitivity pneumonitis (HP) is an increasingly recognized interstitial lung disease caused by exposure to inhaled, mostly organic, antigens. The non-fibrotic type of HP generally follows a benign course. We present 3 patients with a rare presentation of non-fibrotic HP-acute respiratory failure. PATIENT CONCERNS: 2 females and 1 male, presented to the pulmonary department due to resting dyspnea, cough and low-grade fever. Arterial blood gases revealed profound hypoxemia. No relevant abnormalities were found in the blood tests. In high-resolution computed tomography (HRCT), signs of extensive interstitial lung disease were present. Infection was excluded based on genetic testing and cultures. Pulmonary function tests revealed decrease in forced vital capacity (FVC) and transfer factor of the lungs for carbon monoxide (TLco). DIAGNOSES: Non-fibrotic HP was diagnosed based on positive exposure to organic antigens, characteristic lung HRCT pattern, and bronchoalveolar lavage lymphocytosis (in 2 cases). INTERVENTIONS: Oxygen therapy was implemented through the nasal tube, accompanied by intravenous and subsequently oral steroids, gradually tapered. OUTCOMES: Rapid clinical improvement, near-complete regression of interstitial lung disease, significant increase in lung volumes and lung transfer factor for carbon monoxide were observed and maintained with low-dose therapy. LESSONS: Non-fibrotic HP rarely presents as a life-threatening interstitial lung disease, requiring immediate immunosuppressive treatment. In some patients with extensive lung involvement, prolonged steroid therapy is necessary to achieve complete resolution of lung opacities and clinical improvement.

MedicineVol. 105(22)
Good health and well-being
Openalex Percentile: Top 6%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.